Albenvet 360 tablets

Form of application: oral administration.

Active ingredient: Albendazol.

Packaging: Tablets: № 100.

White to light grey tablets .

COMPOSITION

Albenvet 360 tablets:
Albendazol: 360 mg; 
Excipient: Q.S. to 1,8 g;

PHARMACOLOGICAL ACTION

The mechanism of action is to inhibit fumarate reductase enzyme in the Krebs cycle this resulting in the cachexia and death of parasites.

USES

The preparations are used to prevent and treat the following helminthic diseases:

Gastrointestinal helminthiasis: hemonchiasis, nematodiriasis, chabertiasis, bunostomasis, esophagostomiasis, ostertagiosis, trichocephaliasis, strongyloidiasis, neoascaridiasis, ascaridiasis, toxocariasis, ankylostomiasis, uncinariasis, oxyuriasis, delafondiasis, alfortiasis, trichonematosis;
Pulmonary helminthiasis: dictyocaulosis, protostrongylosis, muleriosis, metastrongylosis, prenozomosis ;
Cestodes: monieziasis, tizaniediosis, dipilidiosis.
Trematodes: fasciolosis, dicroceliosis, paramphistomatosis, opisthorchiasis. 

CONTRAINDICATIONS

Not known.

PRECAUTIONS

Animals may only be slaughtered for meat not earlier than 14 days; milk is fit for human food in 2 days of the last use of the preparations.

HOW SUPPLIED

360 tablets: № 100;

STORAGE

Store protected from light in a dry place at a temperature not exceeding 25°C. Shelf life is 24 months.

DOSAGE AND ADMINISTRATION

The preparation is administered orally one time with no diet in the following dosage: